These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28017536)

  • 1. Toxicological potential of acyl glucuronides and its assessment.
    Iwamura A; Nakajima M; Oda S; Yokoi T
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):2-11. PubMed ID: 28017536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicological evaluation of acyl glucuronides utilizing half-lives, peptide adducts, and immunostimulation assays.
    Iwamura A; Ito M; Mitsui H; Hasegawa J; Kosaka K; Kino I; Tsuda M; Nakajima M; Yokoi T; Kume T
    Toxicol In Vitro; 2015 Dec; 30(1 Pt B):241-9. PubMed ID: 26528891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Evaluation of Reactivity and Toxicity of Acyl Glucuronides by [
    Harada H; Toyoda Y; Abe Y; Endo T; Takeda H
    Chem Res Toxicol; 2019 Oct; 32(10):1955-1964. PubMed ID: 31496220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictability of idiosyncratic drug toxicity risk for carboxylic acid-containing drugs based on the chemical stability of acyl glucuronide.
    Sawamura R; Okudaira N; Watanabe K; Murai T; Kobayashi Y; Tachibana M; Ohnuki T; Masuda K; Honma H; Kurihara A; Okazaki O
    Drug Metab Dispos; 2010 Oct; 38(10):1857-64. PubMed ID: 20606003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the risk of idiosyncratic drug toxicity and formation and degradation profiles of acyl-glucuronide metabolites of nonsteroidal anti-inflammatory drugs in rat liver microsomes.
    Shimada H; Ikuta H; Kumazawa K; Nomi M; Shiojiri M; Kawase A; Iwaki M
    Eur J Pharm Sci; 2022 Jul; 174():106193. PubMed ID: 35447304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
    Koga T; Fujiwara R; Nakajima M; Yokoi T
    Drug Metab Dispos; 2011 Jan; 39(1):54-60. PubMed ID: 20926620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation.
    Gunduz M; Argikar UA; Cirello AL; Dumouchel JL
    Drug Metab Lett; 2018; 12(2):84-92. PubMed ID: 29886840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyl glucuronide reactivity in perspective: biological consequences.
    Bailey MJ; Dickinson RG
    Chem Biol Interact; 2003 May; 145(2):117-37. PubMed ID: 12686489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyl glucuronide drug metabolites: toxicological and analytical implications.
    Shipkova M; Armstrong VW; Oellerich M; Wieland E
    Ther Drug Monit; 2003 Feb; 25(1):1-16. PubMed ID: 12548138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR spectroscopic studies on the in vitro acyl glucuronide migration kinetics of Ibuprofen ((+/-)-(R,S)-2-(4-isobutylphenyl) propanoic acid), its metabolites, and analogues.
    Johnson CH; Wilson ID; Harding JR; Stachulski AV; Iddon L; Nicholson JK; Lindon JC
    Anal Chem; 2007 Nov; 79(22):8720-7. PubMed ID: 17944439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions.
    Boelsterli UA
    Curr Drug Metab; 2002 Aug; 3(4):439-50. PubMed ID: 12093359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of Deprotonated Acyl-,
    Niyonsaba E; Easton MW; Feng E; Yu Z; Zhang Z; Sheng H; Kong J; Easterling LF; Milton J; Chobanian HR; Deprez NR; Cancilla MT; Kilaz G; Kenttämaa HI
    Anal Chem; 2019 Sep; 91(17):11388-11396. PubMed ID: 31381321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSPR modelling of
    Tugcu G; Sipahi H
    Xenobiotica; 2019 Sep; 49(9):1007-1014. PubMed ID: 30240283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico prediction of acyl glucuronide reactivity.
    Potter T; Lewis R; Luker T; Bonnert R; Bernstein MA; Birkinshaw TN; Thom S; Wenlock M; Paine S
    J Comput Aided Mol Des; 2011 Nov; 25(11):997-1005. PubMed ID: 22042375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyl glucuronide metabolites: Implications for drug safety assessment.
    Van Vleet TR; Liu H; Lee A; Blomme EAG
    Toxicol Lett; 2017 Apr; 272():1-7. PubMed ID: 28286018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Rapid In Vitro Assay for Assessing Reactivity of Acyl Glucuronides.
    Zhong S; Jones R; Lu W; Schadt S; Ottaviani G
    Drug Metab Dispos; 2015 Nov; 43(11):1711-7. PubMed ID: 26276581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of Carboxylic Acid-Containing Drugs: The Role of Acyl Migration and CoA Conjugation Investigated.
    Lassila T; Hokkanen J; Aatsinki SM; Mattila S; Turpeinen M; Tolonen A
    Chem Res Toxicol; 2015 Dec; 28(12):2292-303. PubMed ID: 26558897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyl glucuronides: the good, the bad and the ugly.
    Regan SL; Maggs JL; Hammond TG; Lambert C; Williams DP; Park BK
    Biopharm Drug Dispos; 2010 Oct; 31(7):367-95. PubMed ID: 20830700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significantly Different Covalent Binding of Oxidative Metabolites, Acyl Glucuronides, and S-Acyl CoA Conjugates Formed from Xenobiotic Carboxylic Acids in Human Liver Microsomes.
    Darnell M; Breitholtz K; Isin EM; Jurva U; Weidolf L
    Chem Res Toxicol; 2015 May; 28(5):886-96. PubMed ID: 25803559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of physicochemical properties on the reactivity and stability of acyl glucuronides
    Camilleri P; Buch A; Soldo B; Hutt AJ
    Xenobiotica; 2018 Sep; 48(9):958-972. PubMed ID: 28967291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.